arrow_back Back to App

HALT Fentanyl Act: Combating Fentanyl and Streamlining Research

The HALT Fentanyl Act aims to tighten control over fentanyl-related substances by classifying them as illegal drugs, potentially enhancing public safety by limiting their availability. Concurrently, it introduces simplified procedures for researchers studying these substances, which could accelerate the development of new medicines and therapies. Citizens may experience increased safety due to reduced illegal fentanyl trafficking, as well as potential benefits from faster medical advancements.
Key points
All chemically similar fentanyl-related substances will be automatically classified as Schedule I controlled substances, simplifying prosecution of traffickers.
Research registration procedures for scientists studying Schedule I substances, including fentanyl, have been streamlined to accelerate medical development.
Researchers can conduct studies at multiple sites under a single registration and manufacture small quantities of substances for research without additional permits.
Transparency in research approval processes is introduced, requiring authorities to publicly disclose special criteria for certain substances.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_6184
Sponsor: Rep. Griffith, H. Morgan [R-VA-9]
Process start date: 2021-12-08
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

HALT Fentanyl Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_6184.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-12-08.

What are the main provisions?

Key points include:

  • All chemically similar fentanyl-related substances will be automatically classified as Schedule I controlled substances, simplifying prosecution of traffickers.
  • Research registration procedures for scientists studying Schedule I substances, including fentanyl, have been streamlined to accelerate medical development.
  • Researchers can conduct studies at multiple sites under a single registration and manufacture small quantities of substances for research without additional permits.
  • Transparency in research approval processes is introduced, requiring authorities to publicly disclose special criteria for certain substances.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Griffith, H. Morgan [R-VA-9].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

CATEGORIES

Courts and Law Health Security